Rep. Edward Markey, D-Mass., on Thursday introduced a measure that would provide the FDA greater regulatory power over compounding pharmacies. His bill goes further than a measure backed by a Senate panel Wednesday, which would cover compounders of sterile drugs that distribute in other states. The FDA would have authority over both sterile and nonsterile products under Markey's bill.

Full Story:

Related Summaries